[DNLI] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -5.07%
YoY- -45.58%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 316,815 9,393 5,847 3,604 4,672 13,604 4,197 1662.87%
PBT 245,708 -58,172 -58,679 -56,898 -53,950 -46,373 -58,650 -
Tax 823 56 79 -135 75 -113 -313 -
NP 244,885 -58,228 -58,758 -56,763 -54,025 -46,260 -58,337 -
Tax Rate -0.33% - - - - - - -
Total Cost 71,930 67,621 64,605 60,367 58,697 59,864 62,534 9.73%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 77.30 -619.91 -1,004.93 -1,575.00 -1,156.36 -340.05 -1,389.97 -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS 2.04 -0.54 -0.56 -0.55 -0.57 -0.48 -0.61 -
EPS Diluted 1.91 -0.54 -0.56 -0.55 -0.56 -0.48 -0.61 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.